Cargando…
Characterization of Tumor Microenvironment in Lung Adenocarcinoma Identifies Immune Signatures to Predict Clinical Outcomes and Therapeutic Responses
BACKGROUND AND OBJECTIVE: Increasing evidence has elucidated the clinicopathological significance of individual TME component in predicting outcomes and immunotherapeutic efficacy in lung adenocarcinoma (LUAD). Therefore, we aimed to investigate whether comprehensive TME-based signatures could predi...
Autores principales: | Chen, Donglai, Wang, Yifei, Zhang, Xi, Ding, Qifeng, Wang, Xiaofan, Xue, Yuhang, Wang, Wei, Mao, Yiming, Chen, Chang, Chen, Yongbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973234/ https://www.ncbi.nlm.nih.gov/pubmed/33747907 http://dx.doi.org/10.3389/fonc.2021.581030 |
Ejemplares similares
-
Could tumor spread through air spaces benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-institutional study
por: Chen, Donglai, et al.
Publicado: (2020) -
Clinical implications and molecular features of tertiary lymphoid structures in stage I lung adenocarcinoma
por: Xu, Xuejun, et al.
Publicado: (2023) -
Genome-Wide Analysis of Lung Adenocarcinoma Identifies Novel Prognostic Factors and a Prognostic Score
por: Chen, Donglai, et al.
Publicado: (2019) -
Does the lymph node yield affect survival in patients with esophageal cancer receiving neoadjuvant therapy plus esophagectomy? A systematic review and updated meta-analysis
por: Chen, Donglai, et al.
Publicado: (2020) -
Benefit of adjuvant chemotherapy for patients with stage IB non-small cell lung cancer: a systematic review and meta-analysis
por: Wang, Xiaofan, et al.
Publicado: (2021)